Genisphere is a targeted drug delivery platform company and provider of an innovative DNA-based nanotechnology called 3DNA. Genisphere seeks additional partnerships with biotechnology and pharmaceutical companies that could benefit from the company's platform technology, which is IP-protected and fully customizable to deliver small molecules, biologics, and nucleic acids in a highly targeted manner.
SonoPlot's Microplotter instruments let you print materials for microelectronics or biological spotting.
The novel ultrasonic technology used in these instruments allows for materials like nanometallic silver, carbon nanotubes, DNA, and proteins to be printed in microscale spots, lines, or other shapes.
Oxford Nanopore Technologies Ltd is developing a disruptive, proprietary technology platform for the direct, electronic analysis of single molecules. The technology is adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule. Consequently, the platform has a broad range of potential applications, including scientific research, personalised medicine, crop science and security/defence.
GeneFluidics, Inc. develops electrochemical sensor platform for molecular analysis. Its solutions perform bioassays with sensitivity to picogram/ml concentrations for immunoassays and femtomolar concentrations for genetic assays.
Applied Biosystems Group, a unit of Applied Biosystems Inc. makes the big machines for life scientists to peer into the details of DNA and proteins. Its product line includes systems that detect the polymerase chain reactions used to identify DNA sequences. The unit also provides gene expression assays for various species, specialized enzymes called reagents, and disposable plastic devices to hold DNA samples.
U.S. Genomics has pioneered commercial applications of single molecule DNA, RNA and protein analysis. The company's innovative technologies which include proprietary technologies for extraction of high grade DNA from complex samples, tagging, microfluidics and genomic mapping, address high value unmet needs in bio-security, human diagnostics, and food and drug contaminant monitoring.
Sensera is a development stage biological sensor company developing products for the Point of Care clinical diagnostics market. The Company has a unique sensor array technology that allows rapid, highly sensitive detection of proteins and DNA sequences.